Health🇬🇧 🇺🇸· 5 hours agoAstraZeneca drops 9% after Wainua heart trial fails main goalWhy it matters: The setback clouds AstraZeneca's push in ATTR cardiomyopathy, while partner Ionis fell 19% and analysts flagged a hit to investor trust.#Astrazeneca#WainuaBloomberg, CNBC +1